WINGS BIOTECH LLP: drug alert entries
Batches made by WINGS BIOTECH LLP (as named by CDSCO) that appear in CDSCO drug alerts: 7 entries. For spurious entries, the named company may be the brand owner rather than the actual maker.
Cefixime Oral Suspension I.P.NSQ
Result: Content for Anhydrous Cefixime
Ibuprofen Tablets I.P. 400 mgNSQ
Result: The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Ibuprofen.
Ibuprofen Tablets IP 400 mgNSQ
Result: The sample does not conform to I.P. w.r.to the tests for Dissolution
Rosuvastatin Tablets IP 20 mgNSQ
Result: The sample does not conform to I.P with respect to the test for Related substances
Ondansetron Tablets IPNSQ
Result: The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the test of Dissolution.
Glimepiride, Pioglitazone Hydrochloride and Metformin Hydrochloride Sustained-release Tablets (2mg/15mg/500mg)NSQ
Result: Assay for Glimepiride" only
Lindane Lotion USP 1%NSQ
Result: The above product is official in IP 2022 (Addendum 2024 W.e.f july 2024) but it is claimed as USP as on Manufacturing date.